Search company, investor...

PharmAkea Therapeutics

pharmakea.com

Claim your profile to get in front of buyers, investors, and analysts.

Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Learn more.

Total Raised

$48M

Investors Count

Deal Terms

Funding, Valuation & Revenue

4 Fundings

PharmAkea Therapeutics's latest funding round was a Merger for on January 7, 2020.

PharmAkea Therapeutics's valuation in October 2013 was $36.95M.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
1/7/2020	Merger		Galecto Biotech		0 FY undefined	2
10/7/2013	Series A	$99M	Subscribe to see more	$36.95M	0 FY undefined	10
10/7/2013	Corporate Minority	$99M	Subscribe to see more		0 FY undefined	10
10/17/2012	Seed	$99M	Subscribe to see more		0 FY undefined	10

Date	1/7/2020	10/7/2013	10/7/2013	10/17/2012
Round	Merger	Series A	Corporate Minority	Seed
Amount		$99M	$99M	$99M
Investors	Galecto Biotech	Subscribe to see more	Subscribe to see more	Subscribe to see more
Valuation		$36.95M
Revenue	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined
Sources	2	10	10	10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

PharmAkea Therapeutics Deal Terms

1 Deal Term

PharmAkea Therapeutics's deal structure is available for 1 funding round, including their Series A from October 07, 2013.

Round	Series A
Funding Date	$99M
Pre-Money Valuation
Post-Money Valuation
Amount Raised	$99M
Shares Authorized
Issuance Price	$99M
Dividend Rate
Liquidation Preferences	$99M
Liquidation Price
Participation	$99M
Conversion Price
Anti Dilution	$99M
General Voting	$99M
Board Voting	$99M
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Series A	$99M			$99M		$99M		$99M		$99M		$99M	$99M	$99M